Supreme Court Hands Bayer Shield as Roundup Suits Ease
The Supreme Court ruling blocks state-law cancer claims against Bayer tied to Roundup, a decision that reshapes litig...
Withdrawal risk during a recession can threaten income stability. This overview highlights risk factors and straightforward mitigation approaches.
26,857 articlesThe Supreme Court ruling blocks state-law cancer claims against Bayer tied to Roundup, a decision that reshapes litig...
Meet Ornith, the open-source coding model built for agents rather than humans. This article breaks down how it works,...
U.S. markets wobbled as Opendoor dropped on margin concerns while housing demand hints kept some optimism alive. This...
Palantir stock down this year has rattled investors. This guide breaks down the fundamentals, what the pullback means...
Cardano faces a pivotal test in 2026 as ADA trades near multi-year lows. Analysts say a $1 reclaim is possible but un...
Two unevenly matched tech players—Amplitude and Agilysys—show how top-line growth and margins shape investor expectat...
Citadel Securities invests $600 million across two rival crypto exchanges, Crypto.com and Kraken, valuing each at $20...
Six big forces could redefine how we borrow, buy, and refinance in 2026. This guide breaks down the economy, the hous...
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
A practical, investor-focused look at delcath (dcth) 2025 earnings prospects. We break down the catalysts, risks, and...
A new round of Iranian strikes tests the region’s missile defenses and buoyed defense stocks, while households weigh ...
Unpack the essential takeaways from MASS's hypothetical Q4 2025 earnings. Learn how to read the transcript, spot marg...